Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42.1M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
12.7M
-
Shares change
-
+309K
-
Total reported value, excl. options
-
$33.4M
-
Value change
-
+$812K
-
Number of buys
-
9
-
Number of sells
-
-5
-
Price
-
$2.63
Significant Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q4 2024
31 filings reported holding NSPR - InspireMD, Inc. - Common Stock, $0.0001 par value as of Q4 2024.
InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.7M shares
of 42.1M outstanding shares and own 30.21% of the company stock.
Largest 10 shareholders include Rosalind Advisors, Inc. (2.5M shares), ORBIMED ADVISORS LLC (2.13M shares), MARSHALL WACE, LLP (1.86M shares), Nantahala Capital Management, LLC (1.67M shares), Soleus Capital Management, L.P. (1.38M shares), Velan Capital Investment Management LP (904K shares), Parkman Healthcare Partners LLC (855K shares), PURA VIDA INVESTMENTS, LLC (451K shares), MILLENNIUM MANAGEMENT LLC (331K shares), and Affiance Financial, LLC (189K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.